Here's Why NRx Pharmaceuticals Stock Dropped Monday
Shares of COVID-19 stock NRx Pharmaceuticals (NASDAQ: NRXP) fell 24% Monday after soaring last week.
Last week, NRX Pharmaceuticals stock nearly tripled in response to a positive clinical trial readout for its lead candidate, Zyesami, and a potential solution to a serious logistics problem. On Monday, the stock was sliding back as investors realized the news that drove the stock through the roof last week isn't such a big deal.
Image source: Getty Images.
Source Fool.com
